• Vancouver Tech Journal
  • Posts
  • Inside Karl Pringle's plan to disrupt the centuries-old approach to drug therapy — and save thousands of lives in the process

Inside Karl Pringle's plan to disrupt the centuries-old approach to drug therapy — and save thousands of lives in the process

The CEO of GenXys on how his startup — through science and software — will put an end to one-size-fits-all treatments and bring prescriptions into the future.

Author

William Johnson
December 14, 2021

logo

Subscribe to Premium to read the rest.

Become a paying subscriber of Premium to get access to this post and other subscriber-only content.

Upgrade

A subscription gets you:

  • ♥️ Supporting Vancouver's tech community
  • 🔑 Exclusive content: In-depth stories that you won’t find anywhere else
  • 🎟 First access to events we put on
  • 🔓 Daily Briefings: The Morning Report, an email digest of need-to-know stories and deals
  • 🧠 Monthly members-only virtual Q&As with investors, founders, and operators
  • 🗓 Discounted and invitation-only events
Already a subscriber?Sign In.